ArticleJournal of translational medicine2017

Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma.

Mikhail Burmakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.